Template:Oral hypoglycemics and insulin analogs/ja: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{Navbox with collapsible groups | name = Oral hypoglycemics and insulin analogs/ja | title = 経口糖尿病治療薬、インスリン製剤およびインスリンアナログ製剤、糖尿病に用いられるその他の薬剤（A10） | state = {{{state<includeonly>|expanded</includeonly>}}} | listclass = hlist | group1 = インスリン/insulin analog/ja|イ..." |
No edit summary |
||
| Line 69: | Line 69: | ||
| group4 = [[Amylin/ja]] | | group4 = [[Amylin/ja]]アナログと[[DACRA/ja|DACRA]] | ||
| list4 = | | list4 = | ||
* [[Cagrilintide/ja]]<sup>§</sup> | * [[Cagrilintide/ja]]<sup>§</sup> | ||
Latest revision as of 16:33, 5 February 2024
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Oral hypoglycemics and insulin analogs|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Oral hypoglycemics and insulin analogs|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Oral hypoglycemics and insulin analogs|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.